Taipei Exchange - Delayed Quote TWD

Tien Liang BioTech Co., Ltd. (4127.TWO)

Compare
40.00
-0.20
(-0.50%)
At close: 1:30:35 PM GMT+8

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TWD.
NameTitlePayExercisedYear Born
Mr. Min-Chung Chi President -- -- --
Junxiong Guo Accounting Supervisor -- -- --

Tien Liang BioTech Co., Ltd.

No. 147, Datong Road
9th Floor Section 1 Xizhi District
New Taipei City
Taiwan
886 2 2648 3099 https://www.tlb.com.tw
Sector: 
Healthcare
Full Time Employees: 
63

Description

Tien Liang BioTech Co., Ltd. manufactures and sells pharmaceutical products in Taiwan and internationally. The company offers Chinese medicine products, such as pills for liver and kidney deficiency, low back pain, sore feet, dizziness, thirst, dry tongue, sore throat, and heel pain, as well as rheumatism, joint pain, traveling pain, wind-cold-dampness, gout, neuralgia, enuresis, hemorrhoids, constipation, athlete's foot, fall injuries, cold, bronchitis, cough, and phlegm indications. It provides western medicine products, including ointment, hair removal cream, tablet, capsule, soreness spray, and pain patch products, as well as pain relief gels. In addition, the company offers healthcare products; and other products for body relaxation and comfort, and relieving discomfort after exercise, as well as tooth products and soaps. The company was founded in 1960 and is based in New Taipei City, Taiwan.

Corporate Governance

Tien Liang BioTech Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

August 27, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers